Molecular Diagnosis & Therapy

, Volume 12, Issue 3, pp 193–198 | Cite as

From the World Literature

News
First Online:
  • 13 Downloads
This is a preview of subscription content, log in to check access.

Reference

  1. National Comprehensive Cancer Network. NCCN updates breast cancer guidelines. Media Release: 2008 Jan 23 [online]. Available from URL: http://www.nccn.org

Reference

  1. Slamon DJ, Mackey J, Robert N, et al., on behalf of the Cancer International Research Group (CIRG). Role of anthracycline-based therapy in the adjuvant treatment of breast cancer: efficacy analyses determined by molecular subtypes of the disease [abstract 13]. Breast Cancer Res Treat 2007 Dec; 106Suppl. 1: 5–6 (plus oral presentation)Google Scholar

Reference

  1. Chlebowski RT, Anderson G, Pettinger M, et al., on behalf of the Womens’ Health Initiative Investigators. Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy. Arch Intern Med 2008 Feb 25; 168(4): 370–7PubMedCrossRefGoogle Scholar

Reference

  1. Ekwueme DU, Gardner JG, Subramanian S, et al. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004. Cancer 2008 Feb 1; 112(3): 626–35PubMedCrossRefGoogle Scholar

Reference

  1. Smith S, Su D, Rigault de la Longrais IA, et al. ERCC1 genotype and phenotype in epithelial ovarian cancer identify patients likely to benefit from paclitaxel treatment in addition to platinum-based therapy. J Clin Oncol 2007 Nov 20; 25(33): 5172–9PubMedCrossRefGoogle Scholar

Reference

  1. Sameshima S, Tomozawa S, Horikoshi H, et al. 5-Fluorouracil-related gene expression in hepatic artery infusion-treated patients with hepatic metastases from colorectal carcinomas. Anticancer Res 2008 Jan–Feb; 28(1): 389–94PubMedGoogle Scholar

Reference

  1. Colomer R, Monzo M, Tusquets I, et al. A single-nucleotide polymorphism in the aromatase gene is associated with the efficacy of the aromatase inhibitor letrozole in advanced breast carcinoma. Clin Cancer Res 2008 Feb 1; 14(3): 811–6PubMedCrossRefGoogle Scholar

Reference

  1. Lynch AI, Boerwinkle E, Davis BR, et al. Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension. JAMA 2008 Jan 23; 299(3): 296–307PubMedCrossRefGoogle Scholar

Reference

  1. Hizawa N, Makita H, Nasuhara Y, et al. Beta-(2)-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD. Chest 2007 Nov; 132(5): 1485–92PubMedCrossRefGoogle Scholar

Reference

  1. Schwarz UI, Ritchie MD, Bradford Y, et al. Genetic determinants of response to warfarin during initial anticoagulation. N Engl J Med 2008 Mar 6; 358(10): 999–1008PubMedCrossRefGoogle Scholar

Reference

  1. Yu H, Lin S, Zhang Y, et al. Intron-2 conversion polymorphism of the aldosterone synthase gene and the antihypertensive response to angiotensin-converting enzyme inhibitors. J Hypertens 2008 Feb; 26(2): 251–6PubMedCrossRefGoogle Scholar

References

  1. 1.
    Maguire AM, Simonelli F, Pierce EA, et al. Safety and efficacy of gene transfer for Leber’s congenital amaurosis. N Engl J Med. Epub 2008 Apr 27Google Scholar
  2. 2.
    Bainbridge JWB, Smith AJ, Barker SS, et al. Effect of gene therapy on visual function in Leber’s congenital amaurosis. N Engl J Med. Epub 2008 Apr 27Google Scholar
  3. 3.
    Miller JW. Preliminary results of gene therapy for retinal degeneration. N Engl J Med. Epub 2008 Apr 27Google Scholar

Reference

  1. Vertex Pharmaceuticals Incorporated. Vertex announces positive results for VX-770, an oral investigational agent that targets a defective protein responsible for cystic fibrosis. Media Release: 27 Mar 2008. Available from URL: http://www.vrtx.com

Reference

  1. Novartis. ACZ885, a new biological drug in development, shows potential in treating serious life-long autoinflammatory diseases. Media Release: 8 Apr 2008. Available from URL: http://www.novartis.com

Reference

  1. Dalhousie University. Dermatology team finds treatment for rare life-ruining condition. Media release: 11 Mar 2008. Available from URL: http://www.newswise.com

Reference

  1. Lubell Y, Reyburn H, Mbakilwa H, et al. The impact of response to the results of diagnostic tests for malaria: cost-benefit analysis. BMJ. Epub 2008 Jan 26Google Scholar

Reference

  1. Schackman B, Scott C, Walensky R, et al. Genetic testing in HIV care: clinical effect and cost-effectiveness of HLA-B*5701 screening to guide first-line abacavir use [abstract no. 911]. 15th Conference on Retroviruses and Opportunistic Infections; 2008 Feb 3; Boston (MA).Google Scholar

Reference

  1. Vanda Pharmaceuticals Inc. Genetic variation associated with treatment response in a clinical study of a new atypical antipsychotic fiaptatm (iloperidone). Media Release: 29 Feb 2008. Available from URL: http://www.vandapharma.com

Reference

  1. Guis S, Balandraud N, Bouvenot J, et al. Influence of −308 A/G polymorphism in the tumor necrosis factor alpha gene on etanercept treatment in rheumatoid arthritis. Arthritis Rheum 2007 Dec 15; 57(8): 1426–30PubMedCrossRefGoogle Scholar

Reference

  1. Han D-H, Joe K-H, Na C, et al. Effect of genetic polymorphisms on smoking cessation: a trial of bupropion in Korean male smokers. Psychiatric Genet 2008 Feb; 18(1): 11–6CrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2008

Personalised recommendations